We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Will COVID-19 Vaccines Need To Be Evaluated and Adapted Regularly?

News   Mar 25, 2021 | Original story from The Charité

 
Will COVID-19 Vaccines Need To Be Evaluated and Adapted Regularly?
 
 
Advertisement
 

RELATED ARTICLES

Denmark To Suspend Rollout of AstraZeneca COVID-19 Vaccine

News

The Danish Health Authority has decided to continue its vaccination programme against COVID-19 without the vaccine from AstraZeneca.

READ MORE

The FDA Calls for Pausing the Use of the Johnson & Johnson COVID-19 Vaccine

News

The United States Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) have recommended pausing the use of the Johnson & Johnson (Janssen) COVID-19 vaccine. In addition, Janssen has declared that it will "proactively delay" the rollout of the vaccine in Europe.

READ MORE

Targeting the Tumor Environment in Pregnancy-Associated Breast Cancer

News

A new study has uncovered how breast cancer cells that develop during or after pregnancy alter their environment to allow the formation of more aggressive tumors.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE